These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7501345)
21. Dyspareunia and sexual dysfunction after vaginal delivery in Thai primiparous women with episiotomy. Chayachinda C; Titapant V; Ungkanungdecha A J Sex Med; 2015 May; 12(5):1275-82. PubMed ID: 25756828 [TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause. Wurz GT; Kao CJ; DeGregorio MW Clin Interv Aging; 2014; 9():1939-50. PubMed ID: 25419123 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction. Vale F; Rezende C; Raciclan A; Bretas T; Geber S Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():92-95. PubMed ID: 30677618 [TBL] [Abstract][Full Text] [Related]
24. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial. Portman D; Palacios S; Nappi RE; Mueck AO Maturitas; 2014 Jun; 78(2):91-8. PubMed ID: 24679891 [TBL] [Abstract][Full Text] [Related]
25. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women. Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE; Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180 [TBL] [Abstract][Full Text] [Related]
26. Sexual Anatomy and Function in Women With and Without Genital Mutilation: A Cross-Sectional Study. Abdulcadir J; Botsikas D; Bolmont M; Bilancioni A; Djema DA; Bianchi Demicheli F; Yaron M; Petignat P J Sex Med; 2016 Feb; 13(2):226-37. PubMed ID: 26827253 [TBL] [Abstract][Full Text] [Related]
27. Sexual inactivity in partnered female cancer survivors. Marino JL; Saunders CM; Hickey M Maturitas; 2017 Nov; 105():89-94. PubMed ID: 28528727 [TBL] [Abstract][Full Text] [Related]
28. Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach. Ettinger B; Hait H; Reape KZ; Shu H Menopause; 2008; 15(5):885-9. PubMed ID: 18779677 [TBL] [Abstract][Full Text] [Related]
29. Sexual function after vaginal surgery for stress incontinence: results of a mailed questionnaire. Lemack GE; Zimmern PE Urology; 2000 Aug; 56(2):223-7. PubMed ID: 10925082 [TBL] [Abstract][Full Text] [Related]
30. Sexual activity and vaginal topography in women with symptomatic pelvic floor disorders. Edenfield AL; Levin PJ; Dieter AA; Amundsen CL; Siddiqui NY J Sex Med; 2015 Feb; 12(2):416-23. PubMed ID: 25293781 [TBL] [Abstract][Full Text] [Related]
31. Changes in vaginal anatomy and sexual function after vaginal surgery. Occhino JA; Trabuco EC; Heisler CA; Klingele CJ; Gebhart JB Int Urogynecol J; 2011 Jul; 22(7):799-804. PubMed ID: 21416284 [TBL] [Abstract][Full Text] [Related]
32. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study. Bachmann GA; Komi JO; Menopause; 2010; 17(3):480-6. PubMed ID: 20032798 [TBL] [Abstract][Full Text] [Related]
33. Vaginal dryness: a comparison of prevalence and interventions in 11 countries. Leiblum SR; Hayes RD; Wanser RA; Nelson JS J Sex Med; 2009 Sep; 6(9):2425-33. PubMed ID: 19627461 [TBL] [Abstract][Full Text] [Related]
34. The impact of vaginal penetration difficulties on the sexual functioning of women and their male partners. Elran E; Bronner G; Uziel N; Eli I; Kitrey ND; Raviv G Eur J Contracept Reprod Health Care; 2014 Oct; 19(5):352-8. PubMed ID: 24999222 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the Effect of Laparoscopic and Abdominal Hysterectomy on Lower Urinary Tract Function, Vaginal Length, and Dyspareunia: A Randomized Clinical Trial. Polat M; Kahramanoglu I; Senol T; Senturk B; Ozkaya E; Karateke A J Laparoendosc Adv Surg Tech A; 2016 Feb; 26(2):116-21. PubMed ID: 26671303 [TBL] [Abstract][Full Text] [Related]
37. The impact of primary Sjögren's syndrome on female sexual function. van Nimwegen JF; Arends S; van Zuiden GS; Vissink A; Kroese FG; Bootsma H Rheumatology (Oxford); 2015 Jul; 54(7):1286-93. PubMed ID: 25652072 [TBL] [Abstract][Full Text] [Related]
38. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Erekson EA; Li FY; Martin DK; Fried TR Menopause; 2016 Apr; 23(4):368-75. PubMed ID: 26645820 [TBL] [Abstract][Full Text] [Related]
39. Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy. Archer DF J Steroid Biochem Mol Biol; 2015 Jan; 145():139-43. PubMed ID: 25201455 [TBL] [Abstract][Full Text] [Related]
40. Patient interest in the Lowdown on Down There: attendance at a vulvovaginal and sexual health workshop post-cancer treatment. Millman R; Jacox N; Sears C; Robinson JW; Turner J; Walker LM Support Care Cancer; 2020 Aug; 28(8):3889-3896. PubMed ID: 31845008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]